Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
738 participants
INTERVENTIONAL
2014-11-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ibuprofen caplet arm
Ibuprofen 400 mg caplet
400 milligram (mg) caplet according to Drug Facts label
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ibuprofen 400 mg caplet
400 milligram (mg) caplet according to Drug Facts label
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject reports taking over-the-counter (OTC) analgesics for pain or fever relief
Exclusion Criteria
* Pregnant or breastfeeding females
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert's Discount Pharmacy
Hoover, Alabama, United States
Pharmacy at the Pig
McCalla, Alabama, United States
Community Clinical Pharmacy
Mesa, Arizona, United States
Garden Drug
Fort Lauderdale, Florida, United States
Pill Box Pharmacy and Medical Supply
Pembroke Pines, Florida, United States
Summerfield Pharmacy
Riverview, Florida, United States
Sutton Family Pharmacy
Dalton, Georgia, United States
Wynn's Pharmacy Inc.
Griffin, Georgia, United States
Goodrich Pharmacy
Andover, Minnesota, United States
Goodrich Pharmacy
Anoka, Minnesota, United States
Goodrich Pharmacy
Blaine, Minnesota, United States
Goodrich Pharmacy
Elk River, Minnesota, United States
Cub Pharmacy Number 1924
Saint Louis Park, Minnesota, United States
Albers' Specialty Pharmacy
Kansas City, Missouri, United States
Countryside Pharmacy
Savannah, Missouri, United States
Texas Road Pharmacy
Monroe, New Jersey, United States
Phil's Pills, Inc.
Albuquerque, New Mexico, United States
Total Health and Wellness Center of Taos
Taos, New Mexico, United States
Kroger Pharmacy #342
Cary, North Carolina, United States
Family Prescription Center
Bethlehem, Pennsylvania, United States
The Medicine Shoppe
Bountiful, Utah, United States
Northview Pharmacy
Layton, Utah, United States
Family Plaza Pharmacy
West Jordan, Utah, United States
Foothills Compounding Pharmacy
Enumclaw, Washington, United States
Ostrom Drugs
Kenmore, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUT
Identifier Type: OTHER
Identifier Source: secondary_id
B3491013
Identifier Type: -
Identifier Source: org_study_id